{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:12:45Z","timestamp":1786122765281,"version":"build-2736575974"},"reference-count":58,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Lower Extremity Wounds"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>\n                    Burn lesions damage the skin's outermost defensive layer, allowing pathogenic microbes including\n                    <jats:italic toggle=\"yes\">Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli<\/jats:italic>\n                    to infiltrate. Silver sulfadiazine (SSD) is an effective antibacterial agent approved by U.S. Food and Drug Administration (US-FDA) and is considered as the gold standard for burn wound treatment. Despite the high degree of efficacy of SSD in burn wound management, it possesses some drawbacks, such as poor solubility, low topical bioavailability and skin irritations. The present study endeavors to develop nanosuspension based SSD nanogel for improving the deliverability of SSD and its therapeutic outcomes for the management of partial thickness burn. The SSD nanosuspension was formulated employing controlled nanoprecipitation approach using various surfactants. The formulation was optimized utilizing one-factor-at-a-time approach and to fetch the optimized formulation of 134.6 nm size. The optimized nanosuspension was incorporated into chitosan gel that offer superior drug release potential, and also offered better spreadability (5.21\u2009\u00b1\u20090.38 g) and extrudability (152.27\u2009\u00b1\u20090.22\u2005gm) that represents the easy application over the skin and extrusion of gel from the tube. The formulation was well tolerated as shown by skin irritation study and offered a superior burn lesion healing characteristics vis-\u00e0-vis the marketed product, even at a lower concentration. Hence, the formulation offers a huge potential in enhancing the clinical outcomes of SSD, especially in the management of partial thickness burn. The developed system with the above mentioned outcomes could be a promising delivery system for partial thickness burn wound management.\n                  <\/jats:p>","DOI":"10.1177\/15347346241309425","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T04:15:57Z","timestamp":1737432957000},"page":"916-928","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Nanotechnological Advances in Burn Wound Care: Silver Sulfadiazine-Loaded Nanosuspension-Based Chitosan-Incorporated Nanogel for Partial Thickness Burns"],"prefix":"10.1177","volume":"25","author":[{"given":"Harshita","family":"Barkat","sequence":"first","affiliation":[{"name":"International Islamic University Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Abul","family":"Barkat","sequence":"additional","affiliation":[{"name":"University of Hafr Al-Batin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisuddin","family":"Ali","sequence":"additional","affiliation":[{"name":"College of Pharmacy, King Saud University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8132-3773","authenticated-orcid":false,"given":"Hazrina","family":"Hadi","sequence":"additional","affiliation":[{"name":"Kulliyyah of Pharmacy, International Islamic University Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"issue":"6","key":"e_1_3_2_2_2","article-title":"Epidemiology, bacteriological profile, and antibiotic sensitivity pattern of burn wounds in the burn unit of a tertiary care hospital","volume":"11","author":"Chaudhary NA","year":"2019","unstructured":"Chaudhary NA, Munawar MD, Khan MT, et al. Epidemiology, bacteriological profile, and antibiotic sensitivity pattern of burn wounds in the burn unit of a tertiary care hospital. Cureus. 2019;11(6):e4794. doi:https:\/\/doi.org\/10.7759\/cureus.4794","journal-title":"Cureus"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0145-5"},{"key":"e_1_3_2_4_2","first-page":"153473462311669","article-title":"Old wine in new bottles: Silver sulfadiazine nanotherapeutics for burn wound management","author":"Abul Barkat H","year":"2023","unstructured":"Abul Barkat H, Abul Barkat M, Ali R, Hadi H, Kasmuri AR. Old wine in new bottles: Silver sulfadiazine nanotherapeutics for burn wound management. Int J Low Extrem Wounds. 2023:15347346231166980. doi:https:\/\/doi.org\/10.1177\/15347346231166980","journal-title":"Int J Low Extrem Wounds"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114769"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/ebj3010014"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkaa047"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1551880"},{"issue":"10","key":"e_1_3_2_9_2","article-title":"A systematic review and meta-analysis comparing burn healing outcomes between silver sulfadiazine and aloe vera","volume":"14","author":"Levin NJ","year":"2022","unstructured":"Levin NJ, Erben Y, Li Y, Brigham TJ, Bruce AJ. A systematic review and meta-analysis comparing burn healing outcomes between silver sulfadiazine and aloe vera. Cureus. 2022;14(10):e30815. doi:https:\/\/doi.org\/10.7759\/cureus.30815","journal-title":"Cureus"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118977"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25214870"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics9050093"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cps.2023.11.003"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17488"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S335039"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11081040"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/406731"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.72451"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dental.2017.07.009"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.08.059"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011272"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijcaap.2022.038"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2017.08.104"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2017.09.012"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2018.04.034"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2016.08.080"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.5812\/ijpr.123824"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15102510"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.04.034"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.01.054"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105548"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S447429"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8894541"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c03762"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-017-0817-y"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7394685"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04894"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-021-03060-6"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-022-00418-4"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/10717540701603746"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2014.896428"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-019-2525-5"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2015.05.035"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S339289"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2020.11.011"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112324"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.3390\/gels9100794"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-015-0293-1"},{"key":"e_1_3_2_49_2","first-page":"463","article-title":"Development and in-vitro evaluation of nanosuspension formulation containing Acyclovir for the treatment of ocular infections","volume":"4","author":"Uma Maheswari R","year":"2013","unstructured":"Uma Maheswari R, Mullaicharam AR. Development and in-vitro evaluation of nanosuspension formulation containing Acyclovir for the treatment of ocular infections. Res J Pharm Biol Chem Sci. 2013;4:463-480.","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.26650\/IstanbulJPharm.2020.0021"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics8030069"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.3390\/gels8020097"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics9050099"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.3390\/gels9030178"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms151120800"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1039\/C6RA28676C"},{"key":"e_1_3_2_57_2","article-title":"Development of polymer and surfactant based naringenin nanosuspension for improvement of stability, antioxidant, and antitumour activity","volume":"2020","author":"Shadab NA","year":"2020","unstructured":"Shadab NA, Alhakamy S, Akhter ZAY, et al. Development of polymer and surfactant based naringenin nanosuspension for improvement of stability, antioxidant, and antitumour activity. J Chem. 2020;2020. https:\/\/doi.org\/10.1155\/2020\/3489393","journal-title":"J Chem"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/gels9070587"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102165"}],"container-title":["The International Journal of Lower Extremity Wounds"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15347346241309425","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15347346241309425","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15347346241309425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:50:44Z","timestamp":1786103444000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15347346241309425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/15347346241309425"],"URL":"https:\/\/doi.org\/10.1177\/15347346241309425","relation":{},"ISSN":["1534-7346","1552-6941"],"issn-type":[{"value":"1534-7346","type":"print"},{"value":"1552-6941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]}}}